Scientists say new tests and treatments are “a game changer” – Newsweek
The big potential benefit, say Alzheimer’s experts, lies in using these drugs, or others soon to come, in conjunction with a second recent development in the field: diagnostic blood tests that can identify the presence of Alzheimer’s-associated proteins. With more than a dozen different blood tests currently undergoing clinical trials, scientists believe that in a few years clinicians may be able to use them to make quick, early diagnoses cheaply, even before patients show any outward symptoms of dementia
CNMRI is Closed for Business 